Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Journal of Diabetes Science and Technology|February 10, 2021
New Clamp-PID Algorithm for Automated Glucose Clamps Improves Clamp QualityCarsten Benesch, Mareike Kuhlenkötter, Leszek Nosek, et al.Diabetes Technology & Therapeutics|December 12, 2019
Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 DiabetesChristoph Kapitza, Leszek Nosek, Wolfgang Schmider, et al.Diabetes, Obesity & Metabolism|October 7, 2016
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trialTim Heise, Eric Zijlstra, Leszek Nosek, et al.Journal of Hypertension|June 24, 2006
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patientsThomas Kaiser, Tim Heise, Leszek Nosek, et al.Diabetes Care|June 3, 2009
Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetesLutz Heinemann, Leszek Nosek, Christoph Kapitza, et al.Journal of Diabetes Science and Technology|April 30, 2011
Automated near-continuous glucose monitoring measured in plasma using mid-infrared spectroscopyThomas Jax, Tim Heise, Leszek Nosek, et al.Diabetes, Obesity & Metabolism|November 25, 2020
A single-dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US- and European-approved versions of insulin aspart Mix 70/30 and SAR341402 rapid-acting solution in subjects with type 1 diabetesChristoph Kapitza, Leszek Nosek, Wolfgang Schmider, et al.Journal of Diabetes Science and Technology|September 19, 2017
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 DiabetesEric Zijlstra, Marek Demissie, Tina Graungaard, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 4, 2014
Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes MellitusTim Heise, Leszek Nosek, Carsten Roepstorff, et al.Journal of Clinical Pharmacology|December 6, 2014
Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrelChristoph Kapitza, Leszek Nosek, Lene Jensen, et al.Pageof 3